Dr Juliann M Althoff, MD | |
3475 N Saratoga St Bldg 993, Oak Harbor, WA 98278-4799 | |
(360) 257-9975 | |
Not Available |
Full Name | Dr Juliann M Althoff |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
Location | 3475 N Saratoga St Bldg 993, Oak Harbor, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578536108 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 01046869A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Juliann M Althoff, MD 3475 N Saratoga St Bldg 993, Oak Harbor, WA 98278-8800 Ph: (360) 257-9975 | Dr Juliann M Althoff, MD 3475 N Saratoga St Bldg 993, Oak Harbor, WA 98278-4799 Ph: (360) 257-9975 |
News Archive
As a result, a new study by Yale University researchers and published on the preprint server medRxiv in August 2020 shows that a new saliva test named SalivaDirect simplifies the test approach, avoids invasive samples collection, and the need for trained personnel to collect specimens.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports that the Moffitt Cancer Center has initiated a Phase 1 study to investigate potential immune biomarkers in both tumor tissue and peripheral blood after intralesional PV-10 injection of melanoma tumors.
Large cities in the U.S. are significantly safer than their rural counterparts, with the risk of injury death more than 20 percent higher in the country. A study to be published online tomorrow in Annals of Emergency Medicine upends a common perception that urban areas are more dangerous than small towns ("Safety in Numbers: Are Major Cities the Safest Places in the U.S.?").
Patients with mid-range coronary artery disease are more likely to get relief from painful angina and less likely to have repeat procedures if they get bypass surgery rather than balloon angioplasty with or without a stent, according to a new report by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services.
Shire plc, the global specialty biopharmaceutical company, today announced that data from one of three Phase III clinical trials for velaglucerase alfa, the company's enzyme replacement therapy (ERT) in development for the treatment of Type 1 Gaucher disease, will be presented at the Lysosomal Disease Network (LDN) World Symposium, February 10-12, 2010 in Miami, Florida.
› Verified 3 days ago
Dr. Daniel Andrew Foster, D.O. Preventive Medicine Medicare: Medicare Enrolled Practice Location: Naval Health Clinic Oak Harbor 3475 N Saratoga Street, Oak Harbor, WA 98278 Phone: 360-257-9501 | |
Keith Godfrey, DO Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3475 N Saratoga St, Oak Harbor, WA 98278 Phone: 360-257-9500 | |
Dr. Jeremy David Mccullough, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3475 N Saratoga St, Oak Harbor, WA 98278 Phone: 360-257-9972 | |
Amy Beth Dettori, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 3475 N Saratoga St, Bldg 993, Oak Harbor, WA 98278 Phone: 360-257-9406 | |
Dr. Michael J Oras, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Eodmu 11, 180 W Tulagi Ave, Oak Harbor, WA 98278 Phone: 360-257-4390 | |
Daniel Liddell, M.D, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Naval Health Clinic Oak Harbor 3475 N Saratoga St, Oak Harbor, WA 98278 Phone: 603-257-9915 |